| Q37376141 | 4-HNE inhibits tube formation and up-regulates chondromodulin-I in human endothelial cells |
| Q34117646 | A functional role of the glycosylated N-terminal domain of chondromodulin-I. |
| Q39361737 | A human embryonic stem cell-derived clonal progenitor cell line with chondrogenic potential and markers of craniofacial mesenchyme |
| Q33947190 | A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. |
| Q54230574 | A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1. |
| Q24645087 | A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation |
| Q52172564 | An immunohistochemical study of the mesenchymal and epithelial components of pulmonary chondromatous hamartomas. |
| Q36194493 | Angiogenesis inhibitors localized in hypovascular mesenchymal tissues: chondromodulin-I and tenomodulin |
| Q38007565 | Antiangiogenic and anticancer molecules in cartilage |
| Q57539904 | Articular Cartilage Glycosaminoglycans Inhibit the Adhesion of Endothelial Cells |
| Q34138325 | BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer |
| Q41985730 | Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis. |
| Q35705456 | Biology of fibrocartilage cells. |
| Q50501176 | Bizarre parosteal osteochondromatous proliferation (Nora's lesion) of the foot. |
| Q41791548 | Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: immunohistochemical analysis |
| Q36875895 | Chm-1 gene-modified bone marrow mesenchymal stem cells maintain the chondrogenic phenotype of tissue-engineered cartilage |
| Q73163903 | Chondromodulin I and pleiotrophin gene expression in bovine cartilage and epiphysis |
| Q34811184 | Chondromodulin I is a bone remodeling factor. |
| Q39681478 | Chondromodulin I is dispensable during enchondral ossification and eye development |
| Q90600607 | Chondromodulin-1 and vascular endothelial growth factor-A expression in esophageal squamous cell carcinoma: accelerator and brake theory for angiogenesis at the early stage of cancer progression |
| Q33456250 | Chondromodulin-1 directly suppresses growth of human cancer cells |
| Q91977180 | Chondromodulin-1 in health, osteoarthritis, cancer, and heart disease |
| Q79119753 | Chondromodulin-I expression in rat articular cartilage |
| Q24303617 | Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis |
| Q38962343 | Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk |
| Q35076965 | Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice |
| Q38802370 | Developmental mechanisms in articular cartilage degradation in osteoarthritis |
| Q53280336 | Developmentally inspired programming of adult human mesenchymal stromal cells toward stable chondrogenesis. |
| Q47739851 | Differential actions of VEGF-A isoforms on perichondrial angiogenesis during endochondral bone formation |
| Q24309476 | Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis |
| Q27027831 | Early arterial differentiation and patterning in the avian embryo model |
| Q64118337 | Effects of X-chromosome Tenomodulin Genetic Variants on Obesity in a Children's Cohort and Implications of the Gene in Adipocyte Metabolism |
| Q50603495 | Endochondral ossification model system: designed cell fate of human epiphyseal chondrocytes during long-term implantation. |
| Q45083884 | Establishment of mice expressing EGFP in the placode‐derived inner ear sensory cell lineage and FACS‐array analysis focused on the regional specificity of the otocyst |
| Q35738536 | Establishment of rat bone mesenchymal stem cell lines stably expressing Chondromodulin I. |
| Q81020759 | Expression and localization of cartilage-specific matrix protein chondromodulin-I mRNA in salivary pleomorphic adenomas |
| Q52119344 | Expression of type I, type II, and type X collagen genes during altered endochondral ossification in the femoral epiphysis of osteosclerotic (oc/oc) mice. |
| Q47936948 | Generation of multiple transcripts from the chicken chondromodulin-I gene and their expression during embryonic development |
| Q33690388 | Hormone regulation of chondrocyte differentiation and endochondral bone formation |
| Q40759573 | Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth |
| Q30752604 | Identification of ciliary epithelial-specific genes using subtractive libraries and cDNA arrays in the avian eye. |
| Q33422336 | Identification of differentially expressed genes in the growth plate of broiler chickens with thiram-induced tibial dyschondroplasia |
| Q51824939 | Immobilization-induced cartilage degeneration mediated through expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and chondromodulin-I. |
| Q73300542 | Immunohistochemical evaluation of cartilage-derived morphogenic protein-1 and -2 in normal human salivary glands and pleomorphic adenomas |
| Q73322767 | Immunohistochemistry of chondromodulin-I in the human intervertebral discs with special reference to the degenerative changes |
| Q42464705 | Impairment of VEGF-A-stimulated lamellipodial extensions and motility of vascular endothelial cells by chondromodulin-I, a cartilage-derived angiogenesis inhibitor |
| Q34346264 | Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair |
| Q33995279 | Localization of chondromodulin-I at the feto-maternal interface and its inhibitory actions on trophoblast invasion in vitro |
| Q89829122 | Loss of tenomodulin expression is a risk factor for age-related intervertebral disc degeneration |
| Q33619544 | Matrilin-1 is an inhibitor of neovascularization |
| Q28506259 | Maturational disturbance of chondrocytes in Cbfa1-deficient mice |
| Q39245619 | Meniscus, articular cartilage and nucleus pulposus: a comparative review of cartilage-like tissues in anatomy, development and function |
| Q36369777 | Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation |
| Q28258322 | Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3 |
| Q39241879 | Molecular characterization and function of tenomodulin, a marker of tendons and ligaments that integrate musculoskeletal components |
| Q22009132 | Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells |
| Q40599762 | Myodulin is a novel potential angiogenic factor in skeletal muscle |
| Q26781297 | Novel endogenous angiogenesis inhibitors and their therapeutic potential |
| Q38179467 | Novel functions for type II procollagen |
| Q28185648 | Post-translational processing of bovine chondromodulin-I |
| Q38987429 | Prenatal exposure to environmental factors and congenital limb defects |
| Q79977811 | Rapamycin retards growth and causes marked alterations in the growth plate of young rats |
| Q49913441 | Scleraxis is a transcriptional activator that regulates the expression of Tenomodulin, a marker of mature tenocytes and ligamentocytes. |
| Q41969006 | Scleraxis is required for maturation of tissue domains for proper integration of the musculoskeletal system |
| Q34552267 | Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes |
| Q52133314 | Sequence analysis of zebrafish chondromodulin-1 and expression profile in the notochord and chondrogenic regions during cartilage morphogenesis. |
| Q30824978 | Spatio-temporal distribution of chondromodulin-I mRNA in the chicken embryo: expression during cartilage development and formation of the heart and eye. |
| Q28138380 | Specific loss of chondromodulin-I gene expression in chondrosarcoma and the suppression of tumor angiogenesis and growth by its recombinant protein in vivo |
| Q39575598 | Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells |
| Q34262295 | Synthetic disulfide-bridged cyclic peptides mimic the anti-angiogenic actions of chondromodulin-I. |
| Q37739467 | Tenomodulin gene and obesity-related phenotypes |
| Q35141783 | The N-terminal cleavage of chondromodulin-I in growth-plate cartilage at the hypertrophic and calcified zones during bone development |
| Q89920520 | The Role of p53-Mediated Signaling in the Therapeutic Response of Colorectal Cancer to 9F, a Spermine-Modified Naphthalene Diimide Derivative |
| Q30313322 | The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma |
| Q53404324 | Time-sequential modulation in expression of growth factors from platelet-rich plasma (PRP) on the chondrocyte cultures. |
| Q43826013 | Vascular regression is required for mesenchymal condensation and chondrogenesis in the developing limb |